(Q45360205)

English

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

scientific article published on 2 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

0 references

liver cirrhosis

0 references

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Roberta D'Ambrosio

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Valérie Paradis

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Maria Francesca Donato

5

object named as

Maria Francesca Donato

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Maria Grazia Rumi

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Guido Ronchi

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Massimo Colombo

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

2 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

532-543

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Natural history of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Reversibility of hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Vascular deterioration in cirrhosis: the big picture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Hepatic microvasculature in liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Measurement of fibrosis in needle liver biopsies: evaluation of a colorimetric method

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Localization of cytochromes P450 in human tissues: implications for chemical toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Immunohistochemical evidence for hepatic progenitor cells in liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Oval cell-mediated liver regeneration: Role of cytokines and growth factors.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Oval cell numbers in human chronic liver diseases are directly related to disease severity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Dicer is required for proper liver zonation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Evolving challenges in hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

21 January 2018

Natural history of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon therapy prolonged life expectancy among chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic organization of the adult human liver: a comparative study of normal, fibrotic, and cirrhotic liver tissue

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional hepatocyte heterogeneity in ammonia metabolism. The intercellular glutamine cycle

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and advanced liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25606

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.25606

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45360205&oldid=2075824356"